# Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder

> **NCT01667926** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 37 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01667926
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667926, "Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01667926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*